Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
about
Strategies in the development of vaccines to prevent infections with group A streptococcusStructure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A StreptococcusIn vivo expression of Streptococcus pyogenes immunogenic proteins during tibial foreign body infectionDisease manifestations and pathogenic mechanisms of Group A Streptococcus.The contribution of non-human primate models to the development of human vaccinesA Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsStreptococcus pyogenes arginine and citrulline catabolism promotes infection and modulates innate immunity.Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology.Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins.Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.Genome-wide discovery of novel M1T1 group A streptococcal determinants important for fitness and virulence during soft-tissue infection.Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
P2860
Q26863366-CD4369BC-3F62-4BEA-B733-3086E0724AFFQ27679389-16D79271-B061-4D64-9D56-D314F9759912Q28395445-EDB2B685-1767-4EF6-8C04-35FFE23674C4Q34413457-B274EBD8-B024-4B25-96E8-DD5DE3FAA110Q35737990-8EC7352E-83A8-41FA-9E8E-2C4AEE515E65Q35870249-ADCF68DF-8B17-47AE-8524-3EB6F9F4B197Q36616151-04EA903E-98F8-4D54-A45F-31A19D560A74Q37027300-C1335718-C0AE-46D3-AEFD-3E05B2DB2223Q37548051-8CBCDDD8-2F53-40DE-83F8-E6E5FF2F7597Q37690778-B843C9C3-42DC-4A49-B8B1-A611C927FBA9Q38607614-6DE7B773-07E8-43D7-8123-6C587C6F6AECQ38612165-3C5ADB3F-4C5C-4938-9E70-933FD1A0EBAAQ38777479-52A7581A-DD6E-4515-AE7C-949A3426B86CQ40083025-4054744B-849B-4DD2-9F20-8A3915D081B0Q42249041-8BD834B1-359B-4538-B0A4-AEC95FAFC042
P2860
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@en
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@nl
type
label
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@en
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@nl
prefLabel
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@en
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@nl
P2093
P2860
P50
P1476
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
@en
P2093
Emiliano Chiarot
G S Chhatwal
Graham Magor
Immaculada Y R Margarit
Jason N Cole
Jon Hartas
Kabada S Sriprakash
Manfred Rohde
Marcus Fulde
Michael R Batzloff
P2860
P2888
P304
P356
10.1007/S00109-012-0897-9
P50
P577
2012-04-14T00:00:00Z